MarginsXMarginsX
Home › Markets › Health Care › DGX

Quest Diagnostics Incorporated (DGX)

DGX trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$262.21
+1.01% on the day
Market cap
$28.8B
Large cap
Revenue · 2025
$11.0B
+11.8% on 2024
Net income · 2025
$992.0M
9.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1022079/000102207926000015/0001022079-26-000015-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerDGX on NYSE
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001022079
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$11.0B
Net income$992.0M
Operating income$1.6B
Net margin9.0%
Operating margin14.1%
Revenue growth+11.8%
Cash$420.0M
Total assets$16.2B
P/E (computed)29.1×
P/S (computed)2.6×

Warning signs

Cash runway
Cash-flow positive
$797.0M cash at September 30, 2026
Share count, 1 year
-1.1%
2025-10-15 to 2026-10-15 · -2.1% over 3 years
Going-concern doubt
No
10-Q filed October 23, 2026
Insider net buying, 12 months
-$37.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-23
Cash and burn$797.0M cash; operating cash flow $487.8M a quarter.Report 2026-09-30
Shares outstanding110,019,073 (2026-10-15); 111,242,362 a year earlier; 112,434,997 three years earlier.Cover page 2026-10-15
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Florham Park, New Jersey, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $37.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$3.1B$312.0M$611.0M$797.0M$5.5B$11.8B10-Q 2026-10-23
Q2 2026
2026-06-30
$3.0B$320.0M$597.0M$626.0M$5.6B$11.6B10-Q 2026-07-23
Q1 2026
2026-03-31
$2.9B$252.0M$278.0M$393.0M$5.7B$11.3B10-Q 2026-04-22
Q4 2025
2025-12-31
$2.8B$245.0M$465.0M$420.0M$5.7B$11.0B10-K 2026-02-26
Q3 2025
2025-09-30
$2.8B$245.0M$563.0M$432.0M$5.7B$10.8B10-Q 2026-10-23
Q2 2025
2025-06-30
$2.8B$282.0M$544.0M$319.0M$5.7B$10.5B10-Q 2026-07-23
Q1 2025
2025-03-31
$2.7B$220.0M$314.0M$188.0M$5.9B$10.2B10-Q 2026-04-22
Q4 2024
2024-12-31
$2.6B$222.0M$464.0M$549.0M$6.2B$9.9B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-04-28
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-10-23
Latest current report
CURRENT REPORT
8-K2026-10-22
Latest proxyDEFA14A2026-04-06

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.6%
1 month+12.6%
3 months+10.0%
Year to date+49.6%
1 year+38.4%
From 52-week high-0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ILMNIllumina Inc.$198.00-4.35%$29.9B
LHLabcorp Holdings Inc.$372.46+0.53%$30.2B
CNCCentene Corporation$74.77+4.91%$37.0B
NTRANatera Inc.$288.48-9.59%$41.8B
GHGuardant Health Inc.$144.03-5.06%$19.5B
HUMHumana Inc.$461.25+2.50%$55.4B
MOHMolina Healthcare Inc$233.09+11.27%$12.2B
CIThe Cigna Group$300.16+1.06%$79.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier